Torrent Pharmaceuticals Limited announced that its Dahej manufacturing facility underwent an inspection by the USFDA. The inspection took place from January 19, 2026, to January 23, 2026. The company has confirmed that the inspection has concluded with zero observations, indicating compliance with USFDA standards. This positive outcome is a significant development for the company's manufacturing operations and its ability to supply products to the US market.
